PETER SANGRA: Open Payments
NPI 1265873947 · SANTA TERESA, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 78 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $160 · 2025 $1,613
Food & beverage: $1,613
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $288 |
| Bausch Health US, LLC | 10 | $216 |
| Otsuka America Pharmaceutical, Inc. | 17 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $177 |
| Supernus Pharmaceuticals, Inc. | 11 | $164 |
| Teva Pharmaceuticals USA, Inc. | 5 | $125 |
| Tris Pharma Inc | 5 | $122 |
| Corium, LLC | 4 | $92 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Neurocrine BioSciences, Inc. | 1 | $40 |
Products named: COBENFY, CAPLYTA, Qelbree, REXULTI, WELLBUTRIN, UZEDY, Dyanavel XR, Azstarys.
Industry payments across NM — which companies pay providers there.
